STEAP2 and prostate carcinoma: Activation of extracellular signal-regulated kinase (ERK), which has previously been implicated in prostate cancer progression, was reported with ectopic expression of STAMP1 in DU145 cells and, conversely, was strongly downregulated in LNCaP cells following STAMP1 knockdown (8).